Reports and outlooks are being released regarding the biopharma industry's prospects for 2026. These reports cover various aspects of the industry, including life sciences, pharmaceuticals, and biotech, with some also looking ahead to 2034. The outlooks appear to address trends, market size, and potential growth areas, including the role of artificial intelligence in drug research and development.